The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Highlights
The global Kidney Cancer Targeted Therapy market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
The major global companies of Kidney Cancer Targeted Therapy include Merck, Novartis, Pfizer, Roche, Amgen, Aveo Pharmaceuticals, Exelixis, Bayer and Eisai, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
Considering the economic change due to COVID-19, Tyrosine Kinase Inhibitors, which accounted for % of the global market of Kidney Cancer Targeted Therapy in 2021, is expected to reach US$ million by 2028, growing at a revised CAGR of % from 2022 to 2028.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Kidney Cancer Targeted Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Kidney Cancer Targeted Therapy.
The Kidney Cancer Targeted Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Kidney Cancer Targeted Therapy market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Kidney Cancer Targeted Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Some of the prominent players reviewed in the research report include:
- Merck
- Novartis
- Pfizer
- Roche
- Amgen
- Aveo Pharmaceuticals
- Exelixis
- Bayer
- Eisai
- Wyeth
Product Type Insights
Global markets are presented by Kidney Cancer Targeted Therapy type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Kidney Cancer Targeted Therapy are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Kidney Cancer Targeted Therapy segment by Type
- Tyrosine Kinase Inhibitors
- mTOR Inhibitors
- EGFR Inhibitors
- Anti-VEGF Monoclonal Antibody
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Kidney Cancer Targeted Therapy market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Kidney Cancer Targeted Therapy market.
Kidney Cancer Targeted Therapy Segment by Application
- Renal Cell Cancer
- Renal Pelvis Cancer
- Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina, Colombia)
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Kidney Cancer Targeted Therapy market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
- This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Kidney Cancer Targeted Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
- This report will help stakeholders to understand the global industry status and trends of Kidney Cancer Targeted Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
- This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
- This report stays updated with novel technology integration, features, and the latest developments in the market
- This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Kidney Cancer Targeted Therapy industry.
- This report helps stakeholders to gain insights into which regions to target globally
- This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Kidney Cancer Targeted Therapy.
- This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Kidney Cancer Targeted Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Kidney Cancer Targeted Therapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Tyrosine Kinase Inhibitors
1.2.3 mTOR Inhibitors
1.2.4 EGFR Inhibitors
1.2.5 Anti-VEGF Monoclonal Antibody
1.3 Market by Application
1.3.1 Global Kidney Cancer Targeted Therapy Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Renal Cell Cancer
1.3.3 Renal Pelvis Cancer
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Kidney Cancer Targeted Therapy Market Perspective (2017-2028)
2.2 Kidney Cancer Targeted Therapy Growth Trends by Region
2.2.1 Kidney Cancer Targeted Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Kidney Cancer Targeted Therapy Historic Market Size by Region (2017-2022)
2.2.3 Kidney Cancer Targeted Therapy Forecasted Market Size by Region (2023-2028)
2.3 Kidney Cancer Targeted Therapy Market Dynamics
2.3.1 Kidney Cancer Targeted Therapy Industry Trends
2.3.2 Kidney Cancer Targeted Therapy Market Drivers
2.3.3 Kidney Cancer Targeted Therapy Market Challenges
2.3.4 Kidney Cancer Targeted Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Kidney Cancer Targeted Therapy Players by Revenue
3.1.1 Global Top Kidney Cancer Targeted Therapy Players by Revenue (2017-2022)
3.1.2 Global Kidney Cancer Targeted Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Kidney Cancer Targeted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Kidney Cancer Targeted Therapy Revenue
3.4 Global Kidney Cancer Targeted Therapy Market Concentration Ratio
3.4.1 Global Kidney Cancer Targeted Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Kidney Cancer Targeted Therapy Revenue in 2021
3.5 Kidney Cancer Targeted Therapy Key Players Head office and Area Served
3.6 Key Players Kidney Cancer Targeted Therapy Product Solution and Service
3.7 Date of Enter into Kidney Cancer Targeted Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Kidney Cancer Targeted Therapy Breakdown Data by Type
4.1 Global Kidney Cancer Targeted Therapy Historic Market Size by Type (2017-2022)
4.2 Global Kidney Cancer Targeted Therapy Forecasted Market Size by Type (2023-2028)
5 Kidney Cancer Targeted Therapy Breakdown Data by Application
5.1 Global Kidney Cancer Targeted Therapy Historic Market Size by Application (2017-2022)
5.2 Global Kidney Cancer Targeted Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Kidney Cancer Targeted Therapy Market Size (2017-2028)
6.2 North America Kidney Cancer Targeted Therapy Market Size by Country (2017-2022)
6.3 North America Kidney Cancer Targeted Therapy Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Kidney Cancer Targeted Therapy Market Size (2017-2028)
7.2 Europe Kidney Cancer Targeted Therapy Market Size by Country (2017-2022)
7.3 Europe Kidney Cancer Targeted Therapy Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Kidney Cancer Targeted Therapy Market Size (2017-2028)
8.2 Asia-Pacific Kidney Cancer Targeted Therapy Market Size by Country (2017-2022)
8.3 Asia-Pacific Kidney Cancer Targeted Therapy Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Kidney Cancer Targeted Therapy Market Size (2017-2028)
9.2 Latin America Kidney Cancer Targeted Therapy Market Size by Country (2017-2022)
9.3 Latin America Kidney Cancer Targeted Therapy Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Kidney Cancer Targeted Therapy Market Size (2017-2028)
10.2 Middle East & Africa Kidney Cancer Targeted Therapy Market Size by Country (2017-2022)
10.3 Middle East & Africa Kidney Cancer Targeted Therapy Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Detail
11.1.2 Merck Business Overview
11.1.3 Merck Kidney Cancer Targeted Therapy Introduction
11.1.4 Merck Revenue in Kidney Cancer Targeted Therapy Business (2017-2022)
11.1.5 Merck Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Kidney Cancer Targeted Therapy Introduction
11.2.4 Novartis Revenue in Kidney Cancer Targeted Therapy Business (2017-2022)
11.2.5 Novartis Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Kidney Cancer Targeted Therapy Introduction
11.3.4 Pfizer Revenue in Kidney Cancer Targeted Therapy Business (2017-2022)
11.3.5 Pfizer Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Kidney Cancer Targeted Therapy Introduction
11.4.4 Roche Revenue in Kidney Cancer Targeted Therapy Business (2017-2022)
11.4.5 Roche Recent Development
11.5 Amgen
11.5.1 Amgen Company Detail
11.5.2 Amgen Business Overview
11.5.3 Amgen Kidney Cancer Targeted Therapy Introduction
11.5.4 Amgen Revenue in Kidney Cancer Targeted Therapy Business (2017-2022)
11.5.5 Amgen Recent Development
11.6 Aveo Pharmaceuticals
11.6.1 Aveo Pharmaceuticals Company Detail
11.6.2 Aveo Pharmaceuticals Business Overview
11.6.3 Aveo Pharmaceuticals Kidney Cancer Targeted Therapy Introduction
11.6.4 Aveo Pharmaceuticals Revenue in Kidney Cancer Targeted Therapy Business (2017-2022)
11.6.5 Aveo Pharmaceuticals Recent Development
11.7 Exelixis
11.7.1 Exelixis Company Detail
11.7.2 Exelixis Business Overview
11.7.3 Exelixis Kidney Cancer Targeted Therapy Introduction
11.7.4 Exelixis Revenue in Kidney Cancer Targeted Therapy Business (2017-2022)
11.7.5 Exelixis Recent Development
11.8 Bayer
11.8.1 Bayer Company Detail
11.8.2 Bayer Business Overview
11.8.3 Bayer Kidney Cancer Targeted Therapy Introduction
11.8.4 Bayer Revenue in Kidney Cancer Targeted Therapy Business (2017-2022)
11.8.5 Bayer Recent Development
11.9 Eisai
11.9.1 Eisai Company Detail
11.9.2 Eisai Business Overview
11.9.3 Eisai Kidney Cancer Targeted Therapy Introduction
11.9.4 Eisai Revenue in Kidney Cancer Targeted Therapy Business (2017-2022)
11.9.5 Eisai Recent Development
11.10 Wyeth
11.10.1 Wyeth Company Detail
11.10.2 Wyeth Business Overview
11.10.3 Wyeth Kidney Cancer Targeted Therapy Introduction
11.10.4 Wyeth Revenue in Kidney Cancer Targeted Therapy Business (2017-2022)
11.10.5 Wyeth Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Kidney Cancer Targeted Therapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Tyrosine Kinase Inhibitors
Table 3. Key Players of mTOR Inhibitors
Table 4. Key Players of EGFR Inhibitors
Table 5. Key Players of Anti-VEGF Monoclonal Antibody
Table 6. Global Kidney Cancer Targeted Therapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Kidney Cancer Targeted Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Kidney Cancer Targeted Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Kidney Cancer Targeted Therapy Market Share by Region (2017-2022)
Table 10. Global Kidney Cancer Targeted Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Kidney Cancer Targeted Therapy Market Share by Region (2023-2028)
Table 12. Kidney Cancer Targeted Therapy Market Trends
Table 13. Kidney Cancer Targeted Therapy Market Drivers
Table 14. Kidney Cancer Targeted Therapy Market Challenges
Table 15. Kidney Cancer Targeted Therapy Market Restraints
Table 16. Global Kidney Cancer Targeted Therapy Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Kidney Cancer Targeted Therapy Market Share by Players (2017-2022)
Table 18. Global Top Kidney Cancer Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer Targeted Therapy as of 2021)
Table 19. Ranking of Global Top Kidney Cancer Targeted Therapy Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Kidney Cancer Targeted Therapy Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Kidney Cancer Targeted Therapy Product Solution and Service
Table 23. Date of Enter into Kidney Cancer Targeted Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Kidney Cancer Targeted Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Kidney Cancer Targeted Therapy Revenue Market Share by Type (2017-2022)
Table 27. Global Kidney Cancer Targeted Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Kidney Cancer Targeted Therapy Revenue Market Share by Type (2023-2028)
Table 29. Global Kidney Cancer Targeted Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Kidney Cancer Targeted Therapy Revenue Market Share by Application (2017-2022)
Table 31. Global Kidney Cancer Targeted Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Kidney Cancer Targeted Therapy Revenue Market Share by Application (2023-2028)
Table 33. North America Kidney Cancer Targeted Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America Kidney Cancer Targeted Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe Kidney Cancer Targeted Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe Kidney Cancer Targeted Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific Kidney Cancer Targeted Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific Kidney Cancer Targeted Therapy Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America Kidney Cancer Targeted Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America Kidney Cancer Targeted Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa Kidney Cancer Targeted Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa Kidney Cancer Targeted Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 43. Merck Company Detail
Table 44. Merck Business Overview
Table 45. Merck Kidney Cancer Targeted Therapy Product
Table 46. Merck Revenue in Kidney Cancer Targeted Therapy Business (2017-2022) & (US$ Million)
Table 47. Merck Recent Development
Table 48. Novartis Company Detail
Table 49. Novartis Business Overview
Table 50. Novartis Kidney Cancer Targeted Therapy Product
Table 51. Novartis Revenue in Kidney Cancer Targeted Therapy Business (2017-2022) & (US$ Million)
Table 52. Novartis Recent Development
Table 53. Pfizer Company Detail
Table 54. Pfizer Business Overview
Table 55. Pfizer Kidney Cancer Targeted Therapy Product
Table 56. Pfizer Revenue in Kidney Cancer Targeted Therapy Business (2017-2022) & (US$ Million)
Table 57. Pfizer Recent Development
Table 58. Roche Company Detail
Table 59. Roche Business Overview
Table 60. Roche Kidney Cancer Targeted Therapy Product
Table 61. Roche Revenue in Kidney Cancer Targeted Therapy Business (2017-2022) & (US$ Million)
Table 62. Roche Recent Development
Table 63. Amgen Company Detail
Table 64. Amgen Business Overview
Table 65. Amgen Kidney Cancer Targeted Therapy Product
Table 66. Amgen Revenue in Kidney Cancer Targeted Therapy Business (2017-2022) & (US$ Million)
Table 67. Amgen Recent Development
Table 68. Aveo Pharmaceuticals Company Detail
Table 69. Aveo Pharmaceuticals Business Overview
Table 70. Aveo Pharmaceuticals Kidney Cancer Targeted Therapy Product
Table 71. Aveo Pharmaceuticals Revenue in Kidney Cancer Targeted Therapy Business (2017-2022) & (US$ Million)
Table 72. Aveo Pharmaceuticals Recent Development
Table 73. Exelixis Company Detail
Table 74. Exelixis Business Overview
Table 75. Exelixis Kidney Cancer Targeted Therapy Product
Table 76. Exelixis Revenue in Kidney Cancer Targeted Therapy Business (2017-2022) & (US$ Million)
Table 77. Exelixis Recent Development
Table 78. Bayer Company Detail
Table 79. Bayer Business Overview
Table 80. Bayer Kidney Cancer Targeted Therapy Product
Table 81. Bayer Revenue in Kidney Cancer Targeted Therapy Business (2017-2022) & (US$ Million)
Table 82. Bayer Recent Development
Table 83. Eisai Company Detail
Table 84. Eisai Business Overview
Table 85. Eisai Kidney Cancer Targeted Therapy Product
Table 86. Eisai Revenue in Kidney Cancer Targeted Therapy Business (2017-2022) & (US$ Million)
Table 87. Eisai Recent Development
Table 88. Wyeth Company Detail
Table 89. Wyeth Business Overview
Table 90. Wyeth Kidney Cancer Targeted Therapy Product
Table 91. Wyeth Revenue in Kidney Cancer Targeted Therapy Business (2017-2022) & (US$ Million)
Table 92. Wyeth Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Kidney Cancer Targeted Therapy Market Share by Type: 2021 VS 2028
Figure 2. Tyrosine Kinase Inhibitors Features
Figure 3. mTOR Inhibitors Features
Figure 4. EGFR Inhibitors Features
Figure 5. Anti-VEGF Monoclonal Antibody Features
Figure 6. Global Kidney Cancer Targeted Therapy Market Share by Application in 2021 & 2028
Figure 7. Renal Cell Cancer Case Studies
Figure 8. Renal Pelvis Cancer Case Studies
Figure 9. Others Case Studies
Figure 10. Kidney Cancer Targeted Therapy Report Years Considered
Figure 11. Global Kidney Cancer Targeted Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Kidney Cancer Targeted Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Kidney Cancer Targeted Therapy Market Share by Region: 2021 VS 2028
Figure 14. Global Kidney Cancer Targeted Therapy Market Share by Players in 2021
Figure 15. Global Top Kidney Cancer Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer Targeted Therapy as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Kidney Cancer Targeted Therapy Revenue in 2021
Figure 17. North America Kidney Cancer Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Kidney Cancer Targeted Therapy Market Share by Country (2017-2028)
Figure 19. United States Kidney Cancer Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Kidney Cancer Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Kidney Cancer Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Kidney Cancer Targeted Therapy Market Share by Country (2017-2028)
Figure 23. Germany Kidney Cancer Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Kidney Cancer Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Kidney Cancer Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Kidney Cancer Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Kidney Cancer Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Kidney Cancer Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Kidney Cancer Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Kidney Cancer Targeted Therapy Market Share by Region (2017-2028)
Figure 31. China Kidney Cancer Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Kidney Cancer Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Kidney Cancer Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Kidney Cancer Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Kidney Cancer Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Kidney Cancer Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Kidney Cancer Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Kidney Cancer Targeted Therapy Market Share by Country (2017-2028)
Figure 39. Mexico Kidney Cancer Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Kidney Cancer Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Kidney Cancer Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Kidney Cancer Targeted Therapy Market Share by Country (2017-2028)
Figure 43. Turkey Kidney Cancer Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Kidney Cancer Targeted Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Merck Revenue Growth Rate in Kidney Cancer Targeted Therapy Business (2017-2022)
Figure 46. Novartis Revenue Growth Rate in Kidney Cancer Targeted Therapy Business (2017-2022)
Figure 47. Pfizer Revenue Growth Rate in Kidney Cancer Targeted Therapy Business (2017-2022)
Figure 48. Roche Revenue Growth Rate in Kidney Cancer Targeted Therapy Business (2017-2022)
Figure 49. Amgen Revenue Growth Rate in Kidney Cancer Targeted Therapy Business (2017-2022)
Figure 50. Aveo Pharmaceuticals Revenue Growth Rate in Kidney Cancer Targeted Therapy Business (2017-2022)
Figure 51. Exelixis Revenue Growth Rate in Kidney Cancer Targeted Therapy Business (2017-2022)
Figure 52. Bayer Revenue Growth Rate in Kidney Cancer Targeted Therapy Business (2017-2022)
Figure 53. Eisai Revenue Growth Rate in Kidney Cancer Targeted Therapy Business (2017-2022)
Figure 54. Wyeth Revenue Growth Rate in Kidney Cancer Targeted Therapy Business (2017-2022)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
